Menu Search
Equities

CVS Health Corp

CVS*:MEX

CVS Health Corp

Actions
  • Price (MXN)1,130.00
  • Today's Change20.00 / 1.80%
  • Shares traded27.00
  • 1 Year change-5.36%
  • Beta--
Data delayed at least 20 minutes, as of Nov 14 2024 20:33 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

CVS Health Corporation is a health solutions company. The Company operates in four segments: Health Care Benefits, Health Services, Pharmacy & Consumer Wellness, and Corporate/Other. Its Health Care Benefits segment offer a range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental and behavioral health plans, medical management capabilities, Medicare Advantage and Medicare supplement plans, and Medicaid health care management services. Its Health Services segment provides a full range of pharmacy benefit management solutions, delivers health care services in its medical clinics, virtually, and in the home, and offers provider enablement solutions. The Pharmacy & Consumer Wellness segment dispenses prescriptions in its retail pharmacies and through its infusion operations, provides ancillary pharmacy services, including pharmacy patient care programs, diagnostic testing and vaccination administration.

  • Revenue in USD (TTM)368.91bn
  • Net income in USD5.02bn
  • Incorporated1996
  • Employees300.00k
  • Location
    CVS Health Corp1 Cvs DrWOONSOCKET 02895-6146United StatesUSA
  • Phone+1 (401) 765-1500
  • Fax+1 (302) 655-5049
  • Websitehttps://cvshealth.com/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.